Authors
Loading...
Research demonstrates binding differences of non-neutralizing antibodies to transferrin receptor 1 in vitro, suggesting implications for pathogen inhibition.
Munoz et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: